
We are a technology-intensive venture company of derma-cosmetics that is founded on the basis of very long R&D experiences of CEO. He has studied over 20 years about sensitive skin including atopic dermatitis, red face, acne, skin aging etc. We have launched moisturizers for atopic dermatitis & baby skincare, a regeneration cream for red face, and an essence for acne. And we will launch a high quality of derma-cosmetics continuously. LA Times Korea selected our company as their partner company after testing our products. We believe that our all products will be very specific at your market because it's scientific and has high quality. Thank you for your attention.
[Company history]
2014. 10. 27 DermaBiotech Co., Ltd. is established
2014. 12. 29 Approved as a marketing authorization holder of cosmetics by KFDA
2015. 10. 05 Acquired a certificate of venture business
2015. 11. 20 ~ 2017. 02. 19 Performing Technological Innovation R&D Program funded by the Small and Medium Business Administration (SMBA, Korea)
“Development of clinically proven moisturizer for sensitive skin by using liquid crystal emulsion technology”
2017. 12. 05 CFDA registration of Dr.BARIA ATO PSL Cream
2017. 12. 22, 2018. 01. 26 Introduction of two articles in LA Times
2018. 04. 25 CFDA registration of CICALINIC PSL Cream
2018. 08. 20 CFDA registration of Dr.BARIA ATO PSL Lotion and ATO Hair & Body Cleanser
2019. 07. 18 Export of “MEDATURE” OEM products to USA and China
2019. 11. 13 Development of “the well deato” OEM products of Pharmaline Co., Ltd.
2019. 12. 17 Received 2019 Seoul Award as excellent product
2020. 04. 13 CFDA registration of CICALINIC HA Bio Essence
2022. 11. 07 Export of Dr. Baumann’s “Zerafite” OEM products to USA
[CEO history]
B.S & M.S, Agricultural Science, Seoul National University, Korea
Ph. D, Medical Science, Yonsei University, Korea (Dermatology Lab)
Postdoctoral Fellowship in UCSF/VAMC: the world best team in skin barrier research
Aekyung Industry Central Research Center
Enprani R&D Center of Skin Science and Cosmetics
Skin Research Team Manager, Cosmax R&I Center
Founding Member of Neopharm. Developer of ATOPALM & ZEROID
Adjunct Professor, College of Pharmacy, Chungbuk National University
Chief of Publishing Committee, The Korean Society for Skin Barrier Research
Evaluator of Technological R&D Program of the Small and Medium Business Administration (SMBA, Korea)
Industry Technologies Exposition Excellence Award
Acquired a Certificate of New Korean Excellent Technology (KT Mark) from Ministry of Science and Technology
Government projects performed: new compounds development or clinical research of atopic allergy, xerosis, skin ageing, etc.